Author:
Resteghini C.,Cavalieri S.,Galbiati D.,Granata R.,Alfieri S.,Bergamini C.,Bossi P.,Licitra L.,Locati L.D.
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism
Reference57 articles.
1. Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial;Brose;Lancet (London, England),2014
2. Lenvatinib versus Placebo in radioiodine-refractory thyroid cancer;Schlumberger;N Engl J Med,2015
3. Vandetanib in patients with locally advanced or metastatic medullary thyroid cancer: a randomized, double-blind phase III trial;Wells;J Clin Oncol,2012
4. Cabozantinib in progressive medullary thyroid cancer;Elisei;J Clin Oncol,2013
5. A phase ii trial of axitinib in patients with various histologic subtypes of advanced thyroid cancer: long-term outcomes and pharmacokinetic/pharmacodynamic analyses;Cohen;Cancer Chemother Pharmacol,2014
Cited by
69 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献